NeuroOne Medical Technologies is pioneering advancements in neuroscience through its innovative thin film electrode technology, which is designed for both diagnostic and therapeutic applications in neurology. The company's focus is primarily on epilepsy and the rapidly expanding neurostimulation device market. Their flagship products include the Evo® sEEG and Evo® Cortical Electrodes, which are minimally invasive and provide high-definition recordings of brain activity. These electrodes are engineered to be significantly thinner and more flexible than traditional silicone electrodes, which helps to reduce patient discomfort and the risk of infection during surgical procedures. The electrodes are intended for temporary use, allowing for effective monitoring and stimulation of electrical signals in the brain.

In addition to their diagnostic capabilities, NeuroOne has developed the OneRF™ Radiofrequency Ablation System, the first FDA-cleared sEEG-RF system. This system enables bedside monitoring, mapping, and ablation, offering a less invasive approach for epilepsy treatment. The OneRF™ system aims to enhance the therapeutic window for patients, potentially leading to reduced seizure frequency or even seizure freedom. NeuroOne's commitment to innovation is evident in their collaboration with leading experts to expand their product portfolio and explore applications for various neurological conditions beyond epilepsy, positioning the company at the forefront of neurosurgical technology.

United States

NeuroOne Medical Technologies is a medical device company that specializes in developing high-definition, minimally invasive thin film electrodes for the diagnosis and treatment of various neurological conditions.

NeuroOne Medical Technologies

Company Details